CRM enters its August 26 Q2 earnings release having recovered sharply from a rough summer — and the short data confirms that many of its doubters have already covered.
Short interest has collapsed by more than a quarter over the past month, falling to 3.4% of the free float. That retreat is the dominant positioning story. The most dramatic move came in the second week of August, when short positions dropped from roughly 39 million shares to around 29 million in a matter of days — a rapid unwinding that coincided with the stock's 23% monthly rally to $209.17. Borrow conditions back up the picture: availability is effectively unlimited, with more than 3,600% of short interest covered by shares available to lend, and the cost to borrow has fallen to just 0.27% — cheap by any measure. Options pricing adds no additional urgency, with the put/call ratio essentially flat relative to its 20-day average and squarely in the middle of its 52-week range. Positioning is loose rather than tense heading into the print.
The analyst community is more divided, and that split is the more interesting tension. Firms that raised targets this week — BMO Capital lifted to $230, Guggenheim held at $228, and Cantor Fitzgerald maintained its $250 target — collectively argue that Salesforce's Customer 360 platform, improving capital returns, and the Agentforce opportunity justify a further re-rating from current levels. The consensus target of $244 implies roughly 17% additional upside. But the sideline crowd is vocal. Morgan Stanley downgraded to Equal-Weight last month, slashing its target from $287 to $185 — a sharp break from the bulls. Citigroup and UBS both lifted targets recently while holding Neutral ratings, a posture that reads as "less wrong than before" rather than "genuinely constructive." The bear case centres on AI monetisation that hasn't yet shown up in organic bookings, aggressive pricing that is souring customer conversations, and a valuation that, even after the summer drawdown, sits at or above peers on several metrics. The trailing PE of around 13x is modest by historical standards, but EV/EBITDA near 9x and a price-to-book above 4x leave limited margin for a revenue miss.
Among close peers, GWRE and HUBS both outperformed CRM on the week — up 7.7% and 7.1% respectively against CRM's 6.6% gain — while WDAY barely moved at 0.7%. The prior earnings print, in late May, delivered a 7.7% one-day gain followed by a further move higher over the following week. That reaction was well-received; this time, with the stock already 23% higher over the past month, the bar for a similar outcome is meaningfully higher.
The August 26 report is therefore less a test of whether Salesforce is growing and more a test of whether Agentforce deployments are translating into the acceleration in organic bookings that bulls have been pricing in — and whether management's tone on enterprise spending gives the recently retreating short sellers any reason to rebuild their positions.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
